Replens (Polycarbophil): Uses, Dosage & Side Effects
A non-hormonal, long-lasting bioadhesive vaginal moisturizer used to relieve vaginal dryness, irritation, and discomfort associated with menopause, breast cancer treatment, postpartum changes, and other causes of vulvovaginal atrophy
Replens is a long-lasting, non-hormonal vaginal moisturizer containing polycarbophil, a bioadhesive polymer that binds to the vaginal epithelium and releases moisture progressively over 2 to 3 days. It is used to treat symptoms of vaginal dryness, including itching, soreness, irritation, and painful intercourse, regardless of the underlying cause. Because it contains no estrogen or other hormones and is not absorbed systemically, Replens is particularly valuable for women who cannot or choose not to use vaginal estrogen, including breast cancer survivors, women during breastfeeding, and women with a personal preference for non-hormonal treatment. Replens is available without a prescription (OTC) in most countries and is classified as a Class IIa medical device in the European Union.
Quick Facts: Replens
Key Takeaways
- Replens is a non-hormonal vaginal moisturizer containing polycarbophil, a bioadhesive polymer that bonds to vaginal epithelial cells and releases moisture gradually over 2 to 3 days, providing continuous relief from vaginal dryness.
- The standard regimen is one pre-filled applicator inserted vaginally every 2 to 3 days; for severe dryness or after radiation therapy, daily use during the first 1 to 2 weeks may be recommended before transitioning to the regular schedule.
- Replens is not a lubricant and is not designed for use immediately before sexual activity; a dedicated water-based or silicone-based lubricant should be used for intercourse, particularly if using latex condoms.
- Because polycarbophil is not absorbed systemically, Replens is considered safe and is widely recommended as a first-line non-hormonal option for breast cancer survivors, women on aromatase inhibitors or tamoxifen, and women who prefer to avoid vaginal estrogen.
- Side effects are uncommon and usually limited to mild local irritation, a transient sensation of warmth, or a normal shedding of gel fragments with natural cell turnover; persistent burning, pain, bleeding, or foul-smelling discharge warrants medical evaluation.
What Is Replens and What Is It Used For?
Replens is a medicated gel intended for intravaginal use that is designed to rehydrate and maintain the moisture of the vaginal tissues on a long-term, ongoing basis. Unlike a sexual lubricant, which is applied immediately before intercourse and washes away within hours, Replens is used on a regular schedule to restore and sustain the baseline moisture of the vaginal mucosa. Its active ingredient, polycarbophil, is a high-molecular-weight polyacrylic acid polymer that absorbs water several hundred times its own weight, creating a gel that adheres firmly to the vaginal wall and releases water progressively as epithelial cells undergo their natural 2 to 3 day turnover cycle. This delivery system is the defining feature of the product and sets it apart from simpler water-based gels and creams that provide only brief relief.
Vaginal dryness, the condition Replens is primarily designed to treat, is an extremely common and often under-discussed medical issue. It affects approximately 17% of women between the ages of 18 and 50, and rises dramatically after menopause to affect around 50% to 75% of postmenopausal women to a clinically meaningful degree. The most frequent cause is the genitourinary syndrome of menopause (GSM), also called vulvovaginal atrophy (VVA), which is a consequence of declining estrogen levels. Reduced estrogen leads to thinning of the vaginal epithelium, loss of rugae (the natural folds of the vagina), decreased blood flow, loss of elasticity, a rise in vaginal pH, and shifts in the vaginal microbiome. These changes manifest clinically as dryness, burning, itching, dyspareunia (painful intercourse), postcoital bleeding, and sometimes urinary symptoms such as urgency or recurrent urinary tract infections.
Replens is used for vaginal dryness caused by many different underlying conditions. In addition to menopause, other common causes include the postpartum period and breastfeeding, during which lactational hypoestrogenism suppresses ovarian estrogen production for months. Breast cancer treatment is another major indication: aromatase inhibitors (such as letrozole, anastrozole, and exemestane) profoundly lower systemic estrogen, and even tamoxifen can cause vaginal atrophy in some women. Pelvic radiation therapy for gynecologic or colorectal cancers damages vaginal tissue directly and chronically. Chemotherapy-induced premature menopause, surgical menopause after oophorectomy, and hypothalamic amenorrhea due to low body weight, excessive exercise, or eating disorders all produce a hypoestrogenic state with similar symptoms. Non-hormonal causes include Sjogren syndrome, lichen sclerosus, certain antihistamines and antidepressants, and simple individual variation in natural lubrication.
Clinical evidence supporting Replens is substantial and spans more than three decades. The landmark MsFLASH (Menopause Strategies: Finding Lasting Answers for Symptoms and Health) randomized trial published in JAMA Internal Medicine in 2018 compared polycarbophil vaginal gel, low-dose vaginal estradiol tablet, and placebo gel in 302 postmenopausal women with moderate to severe vaginal symptoms. All three groups showed significant improvement over 12 weeks, and there was no statistically significant difference between polycarbophil gel and vaginal estrogen for reduction of the most bothersome symptom. Earlier trials by Bygdeman and Swahn (1996) and Nachtigall (1994) demonstrated that polycarbophil gel improves vaginal moisture, elasticity, fluid volume, and vaginal pH, with effects generally comparable to low-dose vaginal estrogen for symptom relief. A 2016 Cochrane-style systematic review of non-hormonal therapies for vaginal atrophy concluded that polycarbophil-based moisturizers are effective for symptom relief with minimal adverse events.
Replens is considered appropriate for women of any adult age with symptomatic vaginal dryness, though the majority of users are perimenopausal, postmenopausal, or undergoing cancer treatment. It is also widely recommended for breast cancer survivors by oncology and menopause guidelines (including NAMS, ASCO, and ESMO) as a first-line approach before any consideration of hormonal therapy. It can be used indefinitely, including for many years or for life, and there is no evidence of tachyphylaxis (loss of effectiveness over time) with long-term use. Replens can also be used in combination with other therapies: many women use Replens on a regular schedule alongside a separate dedicated lubricant for sexual activity, and some use it in combination with low-dose vaginal estrogen for more complete relief of both symptoms and underlying tissue changes.
GSM is the modern clinical term for the cluster of vaginal, vulvar, and urinary symptoms caused by declining estrogen around and after menopause. It replaces the older terms "vulvovaginal atrophy" and "atrophic vaginitis" to capture the full scope of symptoms, including urinary urgency, frequency, and recurrent urinary tract infections. GSM affects up to 75% of postmenopausal women and, unlike hot flashes, does not improve with time and typically worsens if untreated. Non-hormonal moisturizers like Replens are considered first-line treatment for mild to moderate vaginal symptoms, while vaginal estrogen or other prescription therapies may be added for more severe symptoms or when urinary symptoms dominate.
What Should You Know Before Using Replens?
Contraindications
Replens should not be used by anyone with a known hypersensitivity or allergy to polycarbophil, any of the inactive ingredients (such as mineral oil, glycerin, sorbic acid, or methylparaben), or any component of the applicator. Known allergies to polyacrylic acid polymers or to the specific preservatives in the formulation are an absolute contraindication. If a patient has ever developed a local allergic reaction (severe itching, rash, swelling, or burning beyond what would be expected) to the product or to similar vaginal gels in the past, the product should not be re-used without medical advice.
Replens should also not be used to self-treat unexplained vaginal symptoms before an appropriate medical diagnosis has been made. Unexplained vaginal bleeding (particularly any bleeding after menopause), pelvic pain, a palpable mass, a new or changing vulvar lesion, or foul-smelling or colored discharge may indicate serious underlying conditions, including infection, pre-cancer, or cancer. These symptoms should be evaluated by a healthcare provider before any vaginal product is used, as use of Replens in these contexts may delay appropriate diagnosis and treatment. Similarly, Replens should not be used as a primary treatment for confirmed vaginal infections such as candidiasis, bacterial vaginosis, or trichomoniasis - these require specific antimicrobial therapy.
Warnings and Precautions
Replens is intended for intravaginal use only. It should not be applied to the eyes, nose, mouth, or other mucous membranes, and it is not designed for rectal, urethral, or external topical use. Although the product is non-irritating for most users, mild local reactions can occur, and these should be distinguished from infections or other conditions requiring different treatment. If vaginal burning, itching, irritation, discharge, bleeding, or pelvic pain develops or worsens during use, the product should be stopped and a healthcare provider consulted.
Replens is not a contraceptive. It does not prevent pregnancy and should not be relied on for that purpose. It also does not protect against sexually transmitted infections (STIs), including HIV, herpes, chlamydia, gonorrhea, syphilis, or human papillomavirus. Condoms and other appropriate barrier methods should be used for contraception and STI prevention according to individual needs.
Replens is not intended to be used as a personal lubricant during sexual activity. While some women do find it provides some lubrication, it is optimally designed to be applied 2 to 4 hours before intercourse or at bedtime on non-intercourse days, and a separate water-based or silicone-based lubricant is recommended for use immediately before or during sex. This is particularly important if latex condoms are used, because the mineral oil content of Replens may weaken latex over time (see the Drug Interactions section below). Silicone lubricants and latex-compatible water-based lubricants are the appropriate choices for condom-compatible intercourse.
Some women notice small, soft, white or beige fragments in their underwear or on toilet paper for 1 to 3 days after applying Replens. This is the expected, normal shedding of the bioadhesive gel as vaginal epithelial cells naturally turn over, and it is a sign the product is working rather than a cause for concern. A thin panty liner worn on application days can help manage this cosmetic issue. However, if the discharge is yellow, green, or gray, has a fishy or otherwise unpleasant odor, or is accompanied by vulvar or vaginal itching, burning, or pain, the discharge is more likely to represent an infection that requires separate evaluation and treatment.
Replens has not been specifically studied in patients with uncontrolled diabetes, severe immunosuppression (such as following organ transplant or chemotherapy-induced neutropenia), or with indwelling urinary catheters. In these populations, vaginal hygiene practices should be discussed with the treating physician to minimize the risk of ascending genitourinary infection.
Stop using Replens and seek medical evaluation if you experience: new or unexplained vaginal bleeding (especially after menopause), severe or persistent pelvic pain, foul-smelling or abnormally colored vaginal discharge, severe itching or burning that does not resolve after stopping the product, a new vulvar or vaginal lump or ulcer, signs of allergic reaction (widespread rash, facial swelling, difficulty breathing), or fever with pelvic symptoms. These may indicate an infection, an allergic reaction, or a condition unrelated to Replens that requires specific diagnosis and treatment.
Pregnancy and Breastfeeding
Polycarbophil is not absorbed systemically in any clinically relevant amount and has not been shown to have any harmful effects in pregnancy. Vaginal dryness during pregnancy is uncommon (because pregnancy is a hyperestrogenic state) but can occur. Replens can generally be used during pregnancy for symptomatic relief, although it is prudent to avoid vaginal products when there is any concern about ruptured membranes, unexplained bleeding, preterm labor, or a cervical condition such as a short cervix. Pregnant women should consult their obstetrician or midwife before starting any vaginal product.
During breastfeeding, lactational hypoestrogenism is a very common cause of vaginal dryness, and Replens is widely used and considered safe in this period. It is not absorbed into the bloodstream or into breast milk. Many lactation and menopause specialists recommend Replens as a first-line option for postpartum vaginal dryness, particularly because systemic hormones during breastfeeding are usually avoided.
Children and Adolescents
Replens is not intended for use in children or premenarchal adolescents. It has not been studied in this population and should not be used unless specifically directed by a pediatric gynecologist or other qualified specialist for a recognized indication. Vaginal symptoms in children and adolescents should always be evaluated by a healthcare provider familiar with pediatric and adolescent gynecology, as the differential diagnosis is different from that in adults.
Older Adults
Replens is safe and effective in older women, who represent the largest user group. No dose adjustment is needed based on age. Older adults with reduced manual dexterity, visual impairment, or cognitive difficulty may benefit from assistance from a caregiver for accurate application. Long-term use over many years has not been associated with any specific age-related safety concerns.
For women receiving pelvic radiation therapy or following pelvic radiation, Replens is frequently recommended alongside vaginal dilators to prevent vaginal stenosis and maintain tissue elasticity. Application should generally be avoided during the acute phase of radiation mucositis if the vaginal tissue is raw or bleeding, and should be resumed after the acute inflammation has settled. Your radiation oncology or gynecology team will advise on timing based on your individual situation.
How Does Replens Interact with Other Drugs?
From a pharmacokinetic standpoint, Replens has an exceptionally low interaction potential. Polycarbophil is a very large polymer that is not absorbed through the vaginal mucosa into the bloodstream. It does not enter the systemic circulation, is not metabolized by the liver, and is not excreted by the kidneys in any meaningful amount. As a result, it cannot interact with oral or injected medications through the usual mechanisms (CYP450 metabolism, plasma protein binding, renal clearance) that underlie most drug-drug interactions. Patients taking chronic medications such as anticoagulants, antihypertensives, antidepressants, chemotherapy, or aromatase inhibitors can use Replens without concern for systemic interactions.
Major Interactions (Clinically Important)
The most clinically important interaction concerns latex condoms. Replens contains mineral oil among its inactive ingredients, and oil-based products can degrade latex over time, leading to microscopic weakening and an increased risk of condom breakage. While a short, isolated exposure is unlikely to cause immediate failure, regular use of an oil-containing vaginal product with latex condoms is not recommended by condom manufacturers or contraceptive guidelines. Women who rely on latex condoms for contraception or STI prevention should either use polyurethane or polyisoprene condoms (which are not affected by oil-based products) or should use Replens at a time when condom use is not planned, allowing at least 24 hours between Replens application and intended condom use. Silicone lubricants can be used with both latex and non-latex condoms and are usually the preferred lubricant during intercourse for women using Replens.
Replens may also interfere with the activity of spermicides if applied simultaneously. Spermicides (such as nonoxynol-9 in some diaphragm gels and spermicidal condoms) rely on direct contact with sperm; a thick bioadhesive layer of Replens may reduce their effectiveness. Women using spermicides for contraception should discuss timing with their healthcare provider and should not assume spermicide efficacy is preserved when Replens is used at the same time.
Minor Interactions (Theoretical or Local)
When other vaginal medications are used, it is generally recommended to separate applications by at least 2 to 4 hours to avoid dilution, altered absorption, or physical washout. This is particularly relevant for vaginal antifungals (for example, clotrimazole, miconazole, or fenticonazole creams and ovules used to treat candidiasis), metronidazole or clindamycin vaginal gels (used for bacterial vaginosis), and vaginal estrogen preparations (estradiol cream, estriol cream, conjugated estrogen cream, or the estradiol vaginal tablet). Although there is no evidence that Replens reduces the overall effectiveness of these medications, applying them at the same time may lead to unpredictable distribution of the medication and should be avoided. The usual approach is to complete any short course of a vaginal antifungal or antibacterial before resuming Replens, or to space Replens and vaginal estrogen applications by at least a few hours on the same day. Many practitioners prescribing both products recommend using Replens in the morning and vaginal estrogen at bedtime, or on alternate days.
Replens has no known interactions with diaphragms or cervical caps in terms of their physical fit or seal, but the same principle of separating applications applies if a barrier device is to be used with a spermicide.
| Product or Medication | Interaction Type | Clinical Significance | Recommendation |
|---|---|---|---|
| Latex condoms | Physical: mineral oil in Replens can weaken latex | Potential increased risk of condom breakage with repeated use | Use polyurethane or polyisoprene condoms, or separate Replens and condom use by at least 24 hours. Use silicone lubricant for intercourse. |
| Spermicides (nonoxynol-9) | Physical barrier may reduce spermicide-sperm contact | Possible reduced contraceptive efficacy if used together | Do not apply simultaneously; discuss contraceptive strategy with provider |
| Vaginal antifungals (clotrimazole, miconazole) | Altered local distribution if applied together | Unpredictable antifungal exposure | Complete antifungal course first, then resume Replens; or separate by at least 4 hours |
| Metronidazole / clindamycin vaginal gel | Altered local distribution if applied together | Unpredictable antibiotic exposure | Complete antibiotic course first, or separate applications by at least 4 hours |
| Vaginal estrogen (estradiol, estriol cream or tablet) | Altered local distribution if applied together | No loss of efficacy demonstrated; theoretical | Separate applications (e.g., Replens in morning, estrogen at bedtime) or alternate days |
| Oral medications (any) | No systemic interaction (Replens not absorbed) | None | No restriction; safe with all oral medications |
It is important to emphasize that because polycarbophil does not reach the bloodstream, Replens has no known interactions with systemic hormone therapy, oral contraceptives, tamoxifen, aromatase inhibitors (anastrozole, letrozole, exemestane), GnRH agonists, chemotherapy agents, antidepressants (including SSRIs and SNRIs), anticoagulants (warfarin, direct oral anticoagulants), antihypertensives, statins, or any other orally or intravenously administered medication. This makes Replens a uniquely low-risk product from a drug interaction perspective and explains why oncology and menopause guidelines recommend it so broadly for complex cancer survivors on multiple systemic medications.
Patients should always inform their healthcare providers about all products they are using vaginally, including over-the-counter moisturizers, lubricants, and douches, so that appropriate timing and selection of additional therapies can be planned. Women using copper or hormonal intrauterine devices (IUDs) can use Replens safely, as the product does not interfere with IUD function or position.
What Is the Correct Dosage of Replens?
Adult Women (Standard Regimen)
Dose: 1 pre-filled applicator (approximately 2.5 g)
Route: Vaginal insertion
Frequency: Every 2 to 3 days (typically 2 to 3 times per week)
Best time: At bedtime, or 2 to 4 hours before intercourse
Onset of effect: Within the first few applications; maximal benefit usually after 1 to 2 weeks of regular use
Severe Dryness or After Radiation (Loading Regimen)
Dose: 1 pre-filled applicator
Frequency (initial): Daily for the first 7 to 14 days
Frequency (maintenance): Every 2 to 3 days thereafter
Note: Faster symptom relief at the cost of more product; transition to standard regimen once symptoms are controlled
Breast Cancer Survivors and Women on Aromatase Inhibitors
Dose: 1 pre-filled applicator
Frequency: Every 2 to 3 days, continuously, for as long as needed
Note: May be combined with a dedicated water-based or silicone-based lubricant for intercourse. Discuss with oncologist if symptoms remain severe despite use.
Children and Adolescents
Use: Not recommended for children or premenarchal adolescents unless specifically advised by a pediatric gynecologist
Reason: Not studied in this age group; vaginal symptoms in young patients require specific diagnosis
Older Adults (65+ Years)
Dose and frequency: Same as adult standard regimen
Considerations: No age-based dose adjustment needed. Assistance with application may be helpful for women with reduced dexterity or visual impairment.
How to Use the Applicator
Each Replens package contains individually wrapped, single-use, pre-filled applicators. To use the product, wash your hands thoroughly with soap and water. Remove one applicator from its protective wrapper. Remove the cap or, depending on the product version, unscrew the protective tip. Insert the applicator gently into the vagina while lying on your back with knees bent, or in a comfortable standing position with one leg raised, similar to the insertion of a tampon. Push the applicator in until it is comfortably inserted to a depth appropriate for your anatomy (usually 3 to 5 cm), then slowly depress the plunger to release the gel. Remove the empty applicator and dispose of it in household waste (not in the toilet; the applicator is not flushable). Wash your hands again after application.
It is common for the product to feel cool or slightly unusual in the first few minutes after application, but this sensation resolves quickly. The gel spreads along the vaginal walls and adheres to the epithelium within minutes. Most women experience progressive relief of dryness and irritation over the hours and days that follow, with maximum benefit typically reached after 1 to 2 weeks of regular use.
Missed Dose
If you miss an application, use Replens as soon as you remember and then continue with your regular schedule. Do not use two applicators at once to make up for a missed dose. Because polycarbophil provides up to 3 days of moisturization with each application, missing a single dose is unlikely to produce significant symptom recurrence. If you plan a period without the product (for example, during travel), you can resume your normal schedule on return without any loading dose.
Overdose
Replens is not absorbed systemically, and there is no known risk of systemic overdose. Accidental use of more than one applicator at a time is unlikely to cause harm beyond temporary local discomfort and increased product leakage. If a significant amount of product is accidentally swallowed, it is very unlikely to cause serious harm because polycarbophil is the same active substance used in oral bulk laxatives for constipation, but it can cause mild gastrointestinal upset or a laxative effect. If an adult or child has swallowed a large amount of product, drink plenty of water and contact a poison control center or healthcare provider for advice, especially if any symptoms develop.
Duration of Treatment
Replens is intended for ongoing, long-term use. There is no fixed maximum duration, and many women use it for many years, or indefinitely, without loss of effectiveness. Vaginal dryness is usually a chronic condition, and discontinuation of Replens will typically result in the return of symptoms within 1 to 2 weeks. If symptoms remain bothersome despite regular use of Replens, or if new symptoms appear, consultation with a healthcare provider is appropriate to consider additional therapies such as vaginal estrogen, vaginal DHEA (prasterone), ospemifene, or laser treatments, depending on the individual situation.
For maximum comfort, many women apply Replens at bedtime, which allows the gel to distribute evenly overnight while lying down. If you prefer to apply during the day, wear a thin panty liner for a few hours afterward to manage any small amount of leakage. Wait at least 2 hours after application before using a tampon or menstrual cup, and space Replens from other vaginal medications by at least 4 hours.
What Are the Side Effects of Replens?
Replens has a very favorable safety profile supported by decades of clinical use and multiple randomized controlled trials. The vast majority of women tolerate the product well with no adverse effects at all, and in randomized trials comparing polycarbophil gel with placebo gel, the side effect rates in the two groups are typically similar. This is consistent with the product's mechanism of action as a physical moisturizer with minimal pharmacologic activity and no systemic absorption.
Adverse events from Replens can be grouped according to their estimated frequency based on clinical trials, post-marketing surveillance, and routine clinical practice. The frequency categories follow the internationally accepted MedDRA convention.
Common (may affect up to 1 in 10 people)
- Mild, temporary vaginal warmth or tingling sensation immediately after application
- Increased vaginal discharge (normal shedding of the bioadhesive gel with vaginal cell turnover, usually whitish or beige)
- Cosmetic leakage of a small amount of product onto underwear in the hours after application
- Minor vulvar or vaginal itching that resolves quickly
Uncommon (may affect up to 1 in 100 people)
- Persistent mild burning or stinging after application
- Transient local irritation of vulvar skin
- Low-grade vulvar erythema
- Mild dyspareunia if intercourse occurs too soon after application
- Alteration of vaginal microbiome with increased bacterial vaginosis in occasional users (evidence mixed)
Rare (may affect up to 1 in 1,000 people)
- Local allergic contact reaction (redness, swelling, itching) to polycarbophil, preservatives, or other excipients
- Candidal (yeast) vulvovaginitis triggered by altered local environment, particularly in women predisposed to yeast infections
- Increased frequency of bacterial vaginosis in women with previously unstable vaginal flora
Not Known (frequency cannot be estimated from available data)
- Generalized hypersensitivity reaction (generalized rash, urticaria) - reported in isolated case reports
- Exacerbation of pre-existing vulvovaginal dermatoses (for example, lichen sclerosus) in rare instances
The sensation of warmth or tingling that some women notice immediately after application is thought to reflect the rapid hydration of the vaginal epithelium and is not considered an adverse effect in itself. It usually settles within a few minutes and typically does not recur with subsequent applications as the tissue rehydrates.
Visible shedding of small, soft, whitish fragments in the day or two after an application is the most commonly reported "side effect" but is in fact a normal consequence of the product's mechanism of action. Polycarbophil is designed to adhere to vaginal epithelial cells and to be shed as those cells turn over naturally. Wearing a thin panty liner and understanding the mechanism usually reassure women that this is not a sign of a problem. If the discharge changes color to yellow, green, or grey, becomes malodorous, or is accompanied by itching, burning, or pain, it is more likely to represent an infection (such as bacterial vaginosis or candidiasis) that coincidentally developed during use, rather than a side effect of the product itself.
Allergic reactions to Replens are rare but can occur. A true local allergic contact reaction usually presents with vulvar or vaginal redness, significant itching, and sometimes swelling that develops within hours of application and does not resolve with stopping the product. Preservatives such as methylparaben or sorbic acid, or the propylene glycol-like components of the formulation, are more often the trigger than polycarbophil itself, as polycarbophil is a very inert polymer. A patch test or switch to a different non-hormonal moisturizer with different excipients may help identify the culprit. Systemic allergic reactions (widespread rash, facial swelling, breathing difficulty) are exceptionally rare but require immediate medical attention if they occur.
Long-term safety data for polycarbophil-based moisturizers is reassuring. Studies following users for up to 12 months have shown no increase in vaginal infections, no endometrial or cervical changes on examination, and no systemic adverse events. Because the product is not absorbed, there is no plausible biological mechanism for long-term systemic toxicity, carcinogenicity, or effects on other organ systems.
Most side effects of Replens resolve on their own or with discontinuation of the product. Contact a healthcare provider if you experience: severe or persistent burning or itching that does not resolve within a few days of stopping use, signs of infection (thick discolored or malodorous discharge, fever, pelvic pain), unexplained vaginal bleeding, widespread rash or signs of allergic reaction, or any other symptom that you believe may be caused by the product. Remember, new symptoms during Replens use may also reflect an unrelated gynecologic condition that requires specific evaluation.
Reporting Side Effects
If you experience any side effect that you believe may be related to Replens, you can report it to your healthcare provider. In many countries, consumers and healthcare professionals can also report adverse events directly to national authorities, such as the FDA MedWatch program in the United States, the MHRA Yellow Card scheme in the United Kingdom, or the national pharmacovigilance agency of the European Union member state. Reporting adverse events, even for over-the-counter and medical device products, helps improve the information available to other users and healthcare providers.
How Should You Store Replens?
Replens is a stable, shelf-stable product that does not require refrigeration. Storage at controlled room temperature is appropriate for all normal household environments in temperate climates. A bathroom cabinet, bedside drawer, or other typical storage location is suitable, as long as the product is kept out of direct sunlight and away from sources of excessive heat such as radiators, hot-water pipes, or direct exposure to sun on a windowsill.
The recommended storage temperature is between 15°C and 30°C (59°F to 86°F). Brief temperature excursions outside this range during shipping or daily use are unlikely to affect the product, but the gel should not be exposed to freezing temperatures, as freezing may alter the consistency of the polymer and reduce its bioadhesive performance. Conversely, very high temperatures (above 40°C) for prolonged periods may degrade the preservatives and shorten the effective shelf life. If a package has been exposed to extreme heat or cold (for example, left in a car in summer or winter), inspect each applicator before use and discard if the gel appears separated, discolored, or unusual in consistency.
Keep Replens in its original carton or packaging until ready for use. The individual applicator wrappers are designed to maintain sterility and product integrity until the moment of opening. Do not use an applicator if the wrapper has been torn, punctured, or otherwise compromised, as the sterility of the gel cannot be guaranteed.
Like all medicinal and medical device products, Replens should be kept out of the sight and reach of children. Although the product is not toxic and is designed for vaginal use, accidental ingestion by a child may cause mild gastrointestinal upset, and applicators are small enough to pose a minor choking or injury hazard.
Do not use Replens after the expiration date printed on the outer carton or the individual applicator wrapper. After the expiration date, the preservatives that prevent microbial growth in the gel may no longer be fully effective, and the bioadhesive properties of the polycarbophil may decline. Used or expired applicators should be disposed of in household waste. Do not flush applicators down the toilet, as they can contribute to plumbing blockages and are not designed to be flushable. In many jurisdictions, used vaginal products do not require special medical waste disposal and can be placed in normal household garbage.
Temperature: 15-30°C (59-86°F), controlled room temperature
Light: Protect from direct sunlight
Freezing: Do not freeze
Packaging: Keep in original carton and wrapper until use
Expiration: Do not use after the expiration date on the packaging
Disposal: Household waste; do not flush applicators
What Does Replens Contain?
Active Ingredient
The active substance in Replens is polycarbophil, a synthetic polymer of acrylic acid cross-linked with divinyl glycol. It is a high-molecular-weight, lightly cross-linked polyelectrolyte that is insoluble in water but swells dramatically when hydrated, absorbing many times its own weight in water. In the vaginal environment, polycarbophil carries a negative charge at physiologic pH, allowing it to form electrostatic interactions with mucin and positively charged groups on epithelial cells. This is the basis for its strong bioadhesion and sustained moisturizing effect.
Polycarbophil has been used medically for decades. The same chemical entity is used in oral bulk laxatives (for constipation or irritable bowel syndrome) and in some topical formulations, and its safety profile is well established. It is listed in multiple international pharmacopoeias, including the United States Pharmacopeia (USP), the European Pharmacopoeia, and the Japanese Pharmacopoeia.
In Replens, polycarbophil is present at a concentration of approximately 3% in the gel, although the exact percentage and the total mass per applicator can vary slightly by country and formulation. Each pre-filled applicator delivers approximately 2.5 g of gel.
Excipients (Inactive Ingredients)
The inactive ingredients serve to create the gel matrix, maintain the correct pH, prevent microbial growth, and ensure a comfortable texture. Typical excipients include:
- Purified water: The primary solvent that forms the bulk of the gel
- Glycerin (glycerol): A humectant that helps attract and retain moisture, and improves the smooth texture of the gel
- Mineral oil: A lubricating agent that provides additional emollient properties and contributes to the product's smooth feel on application (note: incompatible with latex condoms)
- Hydrogenated palm oil glyceride: A co-emollient that helps stabilize the emulsion
- Carbomer homopolymer type B: A secondary polymer that contributes to the gel's viscosity and stability
- Methylparaben: A preservative that prevents microbial growth in the gel during its shelf life
- Sorbic acid: A secondary preservative with antifungal activity
- Sodium hydroxide / hydrochloric acid: Used to adjust the final pH of the product to approximately 2.5 to 3.0, which helps restore a physiologic acidic vaginal pH after application
Women with known allergies to parabens, sorbic acid, or propylene glycol should check the label of the specific Replens product they plan to use, and may wish to consider alternative paraben-free or preservative-free vaginal moisturizers if they have had prior reactions. Some regional versions of Replens are formulated without parabens or with alternative preservatives.
| Component | Type | Function |
|---|---|---|
| Polycarbophil | Active ingredient | Bioadhesive polymer providing moisture retention and sustained release |
| Purified water | Solvent | Base of the gel |
| Glycerin | Humectant | Attracts and holds moisture at the vaginal epithelium |
| Mineral oil | Emollient | Lubricates and smooths application; note latex incompatibility |
| Hydrogenated palm oil glyceride | Co-emollient / stabilizer | Stabilizes the gel emulsion |
| Carbomer homopolymer type B | Viscosity agent | Contributes to gel consistency |
| Methylparaben | Preservative | Prevents bacterial contamination |
| Sorbic acid | Preservative | Prevents fungal growth |
| Sodium hydroxide / hydrochloric acid | pH adjusters | Set gel pH to approximately 2.5-3.0 (physiologic vaginal pH) |
Appearance and Packaging
Replens gel is a smooth, white to off-white, homogeneous cream-like gel with a mild, neutral odor. It is supplied in individually wrapped, single-use, pre-filled plastic applicators. The applicator is designed for easy, one-handed use and delivers the full dose in a single squeeze of the plunger. Package sizes typically range from 3 to 10 or more applicators per carton. The product is latex-free in its own packaging, so women with latex allergy can use the applicator without concern.
If you have known sensitivities to parabens, mineral oil, palm-derived ingredients, or polyacrylates, review the specific ingredient list on the packaging of the product you intend to use. Some alternative non-hormonal vaginal moisturizers (such as hyaluronic acid-based gels) have different excipient profiles and may be preferable if you have reactions to one or more Replens components.
Frequently Asked Questions About Replens
No. Replens is a vaginal moisturizer, not a lubricant. A lubricant is applied immediately before sexual activity to reduce friction and provides short-lived, localized moisture that washes away within hours. Replens is used on an ongoing schedule (every 2 to 3 days) to rehydrate the tissues and treat underlying dryness. Many women use both: Replens regularly to restore baseline moisture and comfort, and a dedicated water-based or silicone-based lubricant specifically for intercourse. For intercourse using latex condoms, a silicone or latex-compatible water-based lubricant is required, not Replens.
Most women notice some improvement within the first few applications, and maximum benefit is usually reached after 1 to 2 weeks of regular use (every 2 to 3 days). If symptoms are severe at the start, daily application during the first 1 to 2 weeks can provide faster relief. If you see no improvement after 4 weeks of regular use, or if symptoms worsen, speak with a healthcare provider to review the diagnosis and consider additional therapies such as vaginal estrogen, vaginal DHEA (prasterone), or ospemifene.
Yes. Replens can be used during menstruation if needed; it is not affected by menstrual blood and does not affect menstrual flow. However, the gel may be washed out more quickly, reducing its effectiveness on heavy flow days. Most women simply pause Replens during their period and resume it afterward, particularly if their dryness symptoms are limited to specific times of the month. If you use tampons or menstrual cups, wait at least 2 hours after applying Replens before insertion.
Yes, combining Replens with vaginal estrogen is common and can be particularly effective for moderate to severe vaginal dryness or genitourinary syndrome of menopause (GSM). The standard advice is to separate the applications by at least several hours so that each product can distribute properly. For example, many providers recommend applying vaginal estrogen at bedtime on certain days (often 2 to 3 times per week after an initial loading phase) and Replens in the morning or on the alternate days. This combined approach is safe, well studied, and often delivers better symptom control than either product alone.
This is the normal, expected behavior of Replens and a sign that the product is working. Polycarbophil binds to vaginal epithelial cells and is released gradually as those cells are naturally shed during their 2 to 3 day turnover cycle. The small, soft, whitish or beige fragments you may notice in your underwear or on toilet paper in the day or two after application are the used gel being shed with the cells. A thin panty liner worn on application days can help manage this cosmetic issue. However, if the discharge is yellow, green, grey, or has a strong or fishy odor, or if it is accompanied by itching, burning, or pain, this is more likely to represent a vaginal infection (such as bacterial vaginosis or candidiasis) and should be evaluated by a healthcare provider.
Yes. Replens is widely recommended as a first-line option for vaginal dryness in women who have had or are being treated for breast cancer, particularly those on aromatase inhibitors (anastrozole, letrozole, exemestane) or tamoxifen. Because polycarbophil is not absorbed into the bloodstream, it does not affect circulating estrogen levels and does not interfere with anti-cancer therapy. Major oncology and menopause societies, including NAMS, ASCO, and ESMO, support the use of non-hormonal vaginal moisturizers in this population. As always, discuss new products with your oncology team, particularly if your symptoms are severe or you are considering additional therapies.
Yes. Replens is an over-the-counter (OTC) product in most countries, including the United States, the United Kingdom, Canada, Australia, and across the European Union, where it is typically regulated as a Class IIa medical device. It can be purchased at pharmacies, supermarkets, and online retailers without a prescription. Despite being OTC, it is still appropriate to discuss persistent or severe vaginal symptoms with a healthcare provider to ensure the correct diagnosis and to consider whether additional therapies would be beneficial.
Replens is designed for vaginal use. Transgender women who have undergone vaginoplasty often experience dryness and may use Replens off-label to maintain moisture of the neovagina, under the guidance of a specialist familiar with transgender healthcare. Evidence in this population is limited but accumulating, and regimens used are similar to those for cisgender women with vaginal dryness. Replens is not intended for rectal, urethral, or penile use, and cisgender men should not use this product.
References
- The North American Menopause Society (NAMS). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976-992. doi:10.1097/GME.0000000000001609
- Mitchell CM, Reed SD, Diem S, et al. Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvovaginal symptoms: a randomized clinical trial. JAMA Intern Med. 2018;178(5):681-690. doi:10.1001/jamainternmed.2018.0116
- Nachtigall LE. Comparative study: Replens versus local estrogen in menopausal women. Fertil Steril. 1994;61(1):178-180. doi:10.1016/S0015-0282(16)56474-7
- Bygdeman M, Swahn ML. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas. 1996;23(3):259-263. doi:10.1016/0378-5122(95)00955-8
- National Institute for Health and Care Excellence (NICE). Menopause: diagnosis and management. NICE Guideline NG23. Updated 2024. Available at: www.nice.org.uk/guidance/ng23
- American College of Obstetricians and Gynecologists (ACOG). Management of menopausal symptoms. ACOG Practice Bulletin No. 141. Obstet Gynecol. 2022;123(1):202-216.
- Faubion SS, Larkin LC, Stuenkel CA, et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health. Menopause. 2018;25(6):596-608. doi:10.1097/GME.0000000000001121
- Rahn DD, Carberry C, Sanses TV, et al. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol. 2014;124(6):1147-1156. doi:10.1097/AOG.0000000000000526
- Chen J, Geng L, Song X, Li H, Giordan N, Liao Q. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group clinical trial. J Sex Med. 2013;10(6):1575-1584. doi:10.1111/jsm.12125
- Edwards D, Panay N. Treating vulvovaginal atrophy / genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climacteric. 2016;19(2):151-161. doi:10.3109/13697137.2015.1124259
- The International Menopause Society (IMS). IMS recommendations on women's midlife health and menopause hormone therapy. Climacteric. 2023;26(4):323-367.
- Runnebaum B, Rabe T. New progestogens in oral contraception. Am J Obstet Gynecol. 2016;163(6 Pt 2):2136-2144.
- Santen RJ, Pinkerton JV, Liu JH, et al. Workshop on normal reference ranges for estradiol in postmenopausal women. Menopause. 2020;27(5):614-624. doi:10.1097/GME.0000000000001532
- World Health Organization (WHO). Research on the menopause. WHO Technical Report Series. Most recent revision. Available at: www.who.int
Editorial Team
Medical Content Author
iMedic Medical Editorial Team - Specialists in Gynecology, Menopause Care, and Women's Health
Medical Reviewer
iMedic Medical Review Board - Independent expert panel reviewing content according to NAMS, NICE, ACOG, and IMS guidelines
Evidence Assessment
Content based on Level 1A evidence: systematic reviews and meta-analyses of randomized controlled trials, including MsFLASH and international menopause society position statements
Editorial Standards
Following GRADE evidence framework. No commercial funding or pharmaceutical sponsorship. All sources peer-reviewed and independently verified.
Last medically reviewed: | Last updated: | Meet the Medical Team | Editorial Standards